Antiproliferative heparan sulfate inhibiting hyaluronan and transforming growth factor-β expression in human lung fibroblast cells: A possible antifibrotic therapy?

Clinical Proteomics

Volumn 1, Issue 3-4, 2004, Pages 271-284

  Larsen, Kristoffer ^a   Malmström, Johan ^a   Tufvesson, Ellen ^b   Marko Varga, György ^c   Westergren Thorsson, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Annexin II; Cell growth; Fibroblast; Heat shock protein 27; Heparan sulfate; Hyaluronan; Proteoglycan; Transforming growth factor ; Two dimensional gel electrophoresis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; GLYCOSAMINOGLYCAN POLYSULFATE; HEAT SHOCK PROTEIN 27; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; IDURONIC ACID; LIPOCORTIN 2; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASTHMA; CELL ACTIVATION; CELL ACTIVITY; CELL PROLIFERATION; CELL STIMULATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; FETUS; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; LUNG FIBROBLAST; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; RESPIRATORY TRACT DISEASE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 24644468107     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1385/CP:1:3-4:271     Document Type: Article

References (40)

1. Iozzo, R.V. (2001). Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J. Clin. Invest. 108:165-167.
2. Ahmed, T., Garrigo, J., and Danta, I. (1993). Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329:90-95.
3. Lindahl, U., Backstrom, G., Thunberg, L., and Leder, I.G. (1980). Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. USA 77:6551-6555.
4. Culley, F.J., Fadlon, E.J., Kirchem, A., Williams, T.J., Jose, P.J., and Pease, J.E. (2003). Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur. J. Immunol. 33:1302-1310.
5. Garrigo, J., Danta, I., and Ahmed, T. (1996). Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am. J. Respir. Crit. Care Med. 153:1702-1707.
6. Caughey, G.H. (2003). Building a better heparin. Am. J. Respir. Cell Mol. Biol. 28:129-132.
7. Lever, R. and Page, C. (2001). Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm. Pharmacol. Ther. 14:249-254.
8. Jeffery, P.K. (2001). Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164(Pt. 2):S28-S38.
9. Davies, D.E., Wicks, J., Powell, R.M., Puddicombe, S.M., and Holgate, S.T. (2003). Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 111:215-225.
10. Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R.A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3:349-363.
11. Larsen, K., Tufvesson, E., Malmstrom, J., Morgelin, M., Wildt, M., Andersson, A., et al. (2004). Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am. J. Respir. Crit. Care Med. 170:1049-1056.
12. Malmstrom, J., Larsen, K., Hansson, L., Lofdahl, C.G., Norregard-Jensen, O., Marko-Varga, G., et al. (2002). Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2:394-404.
13. Elenius, K., Vainio, S., Laato, M., Salmivirta, M., Thesleff, I., and Jalkanen, M. (1991). Induced expression of syndecan in healing wounds. J. Cell Biol. 114:585-595.
14. Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., et al. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777.
15. Malmstrom, J., Westergren-Thorsson, G., and Marko-Varga, G. (2001). A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis 22:1776-1784.
16. Malmstrom, J., Larsen, K., Malmstrom, L., Tufvesson, E., Parker, K., Marchese, J., et al. (2004). Proteome annotations and identifications of the human pulmonary fibroblast. J. Proteome Res. 3:525-537.
17. Fransson, L.A., Nieduszynski, L.A., and Sheehan, J.K. (1980). Interaction between heparan sulphate chains. I. A gel chromatographic, light-scattering and structural study of aggregating and non-aggregating chains. Biochim. Biophys. Acta 630:287-300.
18. Arroyo-Yanguas, Y., Cheng, F., Isaksson, A., Fransson, L.A., Malmstrom, A., and Westergren-Thorssori, G. (1997). Binding, internalization, and degradation of antiproliferative heparan sulfate by human embryonic lung fibroblasts. J. Cell. Biochem. 64:595-604.
19. Fransson, L.A., Sjoberg, I., and Havsmark, B. (1980). Structural studies on heparan sulphates. Characterization of oligosaccharides; obtained by periodate oxidation and alkaline elimination. Eur. J. Biochem. 106:59-69.
20. Westergren-Thorsson, G., Onnervik, P.O., Fransson, L.A., and Malmstrom, A. (1991). Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J. Cell. Physiol. 147:523-530.
21. Westergren-Thorsson, G., Persson, S., Isaksson, A., Onnervik, P.O., Malmstrom, A., and Fransson, L.A. (1993). L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp. Cell Res. 206:93-99.
22. Westergren-Thorsson, G., Sanistrand, B., Fransson, L.A., and Malmstrom, A. (1990). TGF-beta enhances the production of hyaluronan in human lung but not in skin fibroblasts. Exp. Cell Res. 186:192-195.
23. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
24. Cheng, F., Petersson, P., Arroyo-Yanguas, Y., and Westergren-Thorsson, G. (2001). Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells. J. Cell. Biochem. 83:597-606.
25. Malmstrom, L., Malmstrom, J., Marko-Varga, G., and Westergren-Thorsson, G. (2002). Proteomic 2DE database for spot selection, automated annotation, and data analysis. J. Proteome Res. 1:135-138.
26. Westergren-Thorsson, G., Hernnas, J., Sarnstrand, B., Oldberg, A., Heinegard, D., and Malmstrom, A. (1993). Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:632-637.
27. Kim, S.J., Denhez, F., Kim, K.Y., Holt, J.T., Sporn, M.B., and Roberts, A.B. (1989). Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264:19373-19378.
28. Hausser, H., Groning, A., Hasilik, A., Schonherr, E., and Kresse, H. (1994). Selective inactivity of TGF-beta/decorin complexes. FEBS Lett. 353:243-245.
29. Kolb, M., Margetts, P.J., Sime, P.J., and Gauldie, J. (2001). Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L1327-L1334.
30. Munz, B., Gerke, V., Gillitzer, R., and Werner, S. (1997). Differential expression of the calpactin I subunits annexin II and p11 in cultured keratinocytes and during wound repair. J. Invest. Dermatol. 108:307-312.
31. Gerke, V. and Moss, S.E. (2002). Annexins: from structure to function. Physiol. Rev. 82:331-371.
32. Fitzpatrick, S.L., Kassam, G., Manro, A., Braat, C.E., Louie, P., and Waisman, D.M. (2000). Fucoidan-dependent conformational changes in annexin II tetramer. Biochemistry 39:2140-2148.
33. Dudas, J., Ramadori, G., Knittel, T., Neubauer, K., Raddatz, D., Egedy K., et al. (2000). Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem. J. 350:245-251.
34. Ibitayo, A.I., Sladick, J., Tuteja, S., Louis-Jacques, O., Yamada, H., Groblewski, G., et al. (1999). HSP27 in signal transduction and association with contractile proteins in smooth muscle cells. Am. J. Physiol. 277:G445-G454.
35. Adler, V., Yin, Z., Fuchs, S.Y., Benezra, M., Rosario, L., Tew, K.D., et al. (1999). Regulation of JNK signaling by GSTp. EMBO J. 18:1321-1334.
36. Graven, K.K. and Farber, H.W. (1998). Endothelial cell hypoxic stress proteins. J. Lab. Clin. Med. 132:456-463.
37. Shi, H., Asher, C., Chigaev, A., Yung, Y., Reuveny, E., Seger, R., et al. (2002). Interactions of beta and gamma ENaC with Nedd4 can be facilitated by an ERK-mediated phosphorylation. J. Biol. Chem. 277:13539-13547.
38. Saul, F.A., Arie, J.P., Vulliez-le Normand, B., Kahn, R., Betton, J.M., and Bentley, G.A. (2004). Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity. J. Mol. Biol. 335:595-608.
39. Patterson, C.E., Schaub, T., Coleman, E.J., and Davis, E.C. (2000). Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein. Mol. Biol. Cell 11:3925-3935.
40. Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., et al. (1999). Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 146:843-854.